Adiponectin and noncardiovascular death: a nested case-control study

Metabolism: Clinical and Experimental

Volumn 57, Issue 6, 2008, Pages 811-818

  Matsumoto, Masatoshi ^a   Ishikawa, Shizukiyo ^a   Kajii, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONCARDIOVASCULAR DEATH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE;

ADIPONECTIN; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; ODDS RATIO;

EID: 43849103768     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.01.024     Document Type: Article

References (44)

1. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
2. Berg A.H., Lin Y., Lisanti M.P., and Scherer P.E. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab 287 (2004) E1178-E1188
3. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
4. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
5. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
6. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87 (2002) 2764-2769
7. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
8. Huang K.C., Chen C.L., Chuang L.M., Ho S.R., Tai T.Y., and Yang W.S. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 88 (2003) 4130-4134
9. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148 (2003) 293-300
10. Chandran M., Phillips S.A., Ciaraldi T., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2450
11. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
12. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., and Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92 (2007) 571-576
13. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
14. Chen M.P., Tsai J.C., Chung F.M., Yang S.S., Hsing L.L., Shin S.J., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 821-826
15. Wei E.K., Giovannucci E., Fuchs C.S., Willett W.C., and Mantzoros C.S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97 (2005) 1688-1694
16. Ishikawa M., Kitayama J., Kazama S., Hiramatsu T., Hatano K., and Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 11 (2005) 466-472
17. Dal Maso L., Augustin L.S., Karalis A., Talamini R., Franceschi S., Trichopoulos D., et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89 (2004) 1160-1163
18. Mantzoros C., Petridou E., Dessypris N., Chavelas C., Dalamaga M., Alexe D.M., et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89 (2004) 1102-1107
19. Arditi J.D., Venihaki M., Karalis K.P., and Chrousos G.P. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 39 (2007) 9-13
20. Spyridopoulos T.N., Petridou E.T., Skalkidou A., Dessypris N., Chrousos G.P., and Mantzoros C.S. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120 (2007) 1573-1578
21. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
22. Laughlin G.A., Barrett-Connor E., May S., and Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 165 (2007) 164-174
23. Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Clark L.T., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 27 (2006) 2300-2309
24. Rathmann W., and Herder C. Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology". Horm Metab Res 39 (2007) 1-2
25. Tsao T.S., Lodish H.F., and Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440 (2002) 213-221
26. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
27. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
28. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., and Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36 (2005) 1915-1919
29. Ishikawa S., Gotoh T., Nago N., and Kayaba K. The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios. J Epidemiol 12 (2002) 408-417
30. Tietge U.J., Boker K.H., Manns M.P., and Bahr M.J. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 287 (2004) E82-E89
31. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1198-1201
32. Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., and Kouroumalis E.A. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 100-105
33. Sada K.E., Yamasaki Y., Maruyama M., Sugiyama H., Yamamura M., Maeshima Y., et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33 (2006) 1545-1552
34. Pilz S., Mangge H., Wellnitz B., Seelhorst U., Winkelmann B.R., Tiran B., et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 91 (2006) 4277-4286
35. Menon V., Li L., Wang X., Greene T., Balakrishnan V., Madero M., et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2599-2606
36. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
37. Moschos S.J., and Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63 (2002) 317-332
38. Pischon T., Girman C.J., Rifai N., Hotamisligil G.S., and Rimm E.B. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 81 (2005) 780-786
39. Kato Y., Nakata K., Omagari K., Furukawa R., Kusumoto Y., Mori I., et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74 (1994) 2234-2238
40. Kubo S., Nishiguchi S., Hirohashi K., Tanaka H., Tsukamoto T., Hamba H., et al. High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan. Hepatogastroenterology 46 (1999) 357-359
41. Kojima S., Funahashi T., Sakamoto T., Miyamoto S., Soejima H., Hokamaki J., et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89 (2003) 667
42. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
43. Iwashima Y., Katsuya T., Ishikawa K., Kida I., Ohishi M., Horio T., et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005) 1094-1100
44. Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008;39:323-8.